Related Experiment Video
Updated: Jun 22, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Microalbuminuria among type-2 diabetes mellitus patients in Pokhara, Nepal
M Sigdel1, N Rajbhandari, S Basnet
1The School of Pharmaceuticals and Biomedical Sciences, Pokhara University, Kaski, Nepal. _manojsigdel11@hotmail.com
Abstract:
Microalbuminuria is considered to be an early stage of diabetic nephropathy as well as a marker of cardiovascular disease. The aim of this study was to see the prevalence of microalbuminuria in type 2 diabetic patients and assess its association with cardiovascular risk factors among them. A total of 143 type 2 diabetic patients with the mean age of 56.06 +/- 1.08 years were analysed. The prevalence of microalbuminuria and overt proteinuria was 45.5% and 11.2%, respectively. Prevalence of microalbuminuria in female was marginally higher than in male (p > 0.05). Subjects with microalbuminuria had significantly higher blood pressure (p < 0.001) and duration of diabetes (p < 0.05) compared with normoalbuminuric subjects. High density lipoprotein was found to be significantly lower (p < 0.05) in subjects with microalbuminuria whereas fasting blood sugar, triglyceride, total cholesterol and very low density lipoprotein were marginally higher in microalbuminuric than in normoalbuminuric subjects (p > 0.05). High prevalence of microalbuminuria in diabetic patients and its positive association with blood pressure and altered lipid profile suggests that screening for microalbuminuria is essential for intervention and prevent further complications like end stage renal disease and cardiovascular diseases.
Insights
Microalbuminuria, an early sign of diabetic kidney disease, is prevalent in 45.5% of type 2 diabetes patients. Early screening for microalbuminuria is crucial for managing cardiovascular risks and preventing kidney disease progression.
Area of Science:
- Endocrinology
- Nephrology
- Cardiology
Background:
- Microalbuminuria signifies early diabetic nephropathy and cardiovascular disease risk.
- Type 2 diabetes is a growing global health concern.
- Early detection of complications is vital for patient outcomes.
Purpose of the Study:
- To determine the prevalence of microalbuminuria in type 2 diabetes patients.
- To investigate the association between microalbuminuria and cardiovascular risk factors.
- To highlight the importance of screening for early intervention.
Main Methods:
- Cross-sectional analysis of 143 type 2 diabetes patients.
- Assessment of microalbuminuria and overt proteinuria.
- Evaluation of cardiovascular risk factors including blood pressure, lipid profile, and diabetes duration.
Main Results:
- Prevalence of microalbuminuria was 45.5%; overt proteinuria was 11.2%.
- Microalbuminuria correlated significantly with higher blood pressure and longer diabetes duration.
- Lower high-density lipoprotein levels were observed in patients with microalbuminuria.
Conclusions:
- A high prevalence of microalbuminuria exists in type 2 diabetes patients.
- Microalbuminuria is associated with key cardiovascular risk factors like hypertension.
- Screening for microalbuminuria is essential for preventing diabetic nephropathy and cardiovascular complications.
Related Concept Videos
Diabetic Nephropathy
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Nephrotic Syndrome II : Assessment and Medical Management
Type I Diabetes III: Clinical Manifestations
Diabetes Mellitus: Type 2 and Gestational
Hyperglycemia
